12
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Neuroleptic malignant syndrome and clozapine monotherapy

, &
Pages 692-693 | Published online: 06 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Joanna Fitzsimons, Michael Berk, Timothy Lambert, Michel Bourin & Seetal Dodd. (2005) A review of clozapine safety. Expert Opinion on Drug Safety 4:4, pages 731-744.
Read now
Debra K Farver. (2003) Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opinion on Drug Safety 2:1, pages 21-35.
Read now
Garry Walter, Joseph M. Rey & Floor Dekker. (2001) The humble case report. Australian and New Zealand Journal of Psychiatry 35:2, pages 240-245.
Read now
Vanessa Johnson & George Bruxner. (1998) Neuroleptic Malignant Syndrome Associated with Olanzapine. Australian and New Zealand Journal of Psychiatry 32:6, pages 884-886.
Read now
Ron Bell, Andrew McLaren, Jason Gaianos & David Copolov. (1998) The clinical use of plasma clozapine levels. Australian and New Zealand Journal of Psychiatry 32:4, pages 567-574.
Read now
. (1997) Correspondence. Australian and New Zealand Journal of Psychiatry 31:3, pages 429-438.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.